Response.
Centre of Respiratory Medicine, University College London, Royal Free Campus, London, England. Electronic address: j.wedzicha@ucl.ac.uk.
Jadwiga A
JA
Wedzicha
Krakenhaus Grosshansdorf, Center for Pulmonology and Thoracic Surgery, Grosshansdorf, Germany.
Klaus F
KF
Rabe
Department of Internal Medicine, University of Michigan Medical Center Ann Arbor, MI.
Fernando J
FJ
Martinez
Department of Respiratory Medicine, Nycomed: a Takeda Company, Konstanz, Germany.
Dirk
D
Bredenbröker
Department of Analytical Science, Takeda Pharmaceuticals International GmbH.
Manja
M
Brose
Department of Respiratory Medicine, Nycomed: a Takeda Company, Konstanz, Germany.
Udo-Michael
UM
Goehring
University of Liverpool, Liverpool, England.
Peter M A
PMA
Calverley
D000631:Aminopyridines / Q000627:therapeutic use*; D001549:Benzamides / Q000627:therapeutic use*; D018450:Disease Progression; D005260:Female; D006801:Humans; D008297:Male; D010641:Phenotype; D058988:Phosphodiesterase 4 Inhibitors / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000188:drug therapy*
D000631:Aminopyridines; D001549:Benzamides; D058988:Phosphodiesterase 4 Inhibitors